Arrowhead Pharmaceuticals, Inc. (Nasdaq ARWR) is a commercial stage biopharmaceutical company that develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. Arrowhead is focused on developing innovative drugs for diseases with a genetic basis, typically characterized by the overproduction of one or more proteins that are involved with disease. The depth and versatility of our RNAi technologies enables us to potentially address conditions in virtually any therapeutic area and pursue disease targets that are not otherwise addressable by small molecules and biologics. Arrowhead is leading the field in bringing the promise of RNAi to address diseases outside of the liver, and our clinical pipeline includes disease targets in the liver and lung with a promising pipeline of preclinical candidates. Arrowhead’s corporate headquarters is in Pasadena, CA with research and development teams in Madison, WI & San Diego, CA, and a state of the art manufacturing facility in Verona, WI. Our employees are nimble, science-driven innovators who are collaborating to bring new therapies to patients in need. The Position Let’s do something amazing together! The Sr. Director, Marketing will play a critical role in leading brand strategy and execution for Plozasiran, an siRNA therapy targeting APOC3 for patients with Familial Chylomicronemia Syndrome (FCS) and Severe Hypertriglyceridemia (sHTG). This is a high-visibility leadership role responsible for shaping marketing strategy, building a high-performing team, and driving cross-functional alignment to ensure launch success. Over time, the scope may expand to include additional cardiometabolic indications and pipeline products, including Zodasiran. Patients are counting on us to deliver with speed and excellence. This role offers the opportunity to shape the commercial future of a first-in-class therapy and make a direct impact on patients living with serious, underserved lipid disorders. This role is based in Pasadena, California, with an expectation to be in the office five days a week.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior